1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

CEO search

Discussion in 'American Pathology Partners' started by anonymous, Mar 29, 2018 at 7:12 PM.

  1. anonymous

    anonymous Guest

    What are you hearing?
     
  2. anonymous

    anonymous Guest

    The company is a joke and for sale
     
  3. anonymous

    anonymous Guest

    Is this company still around? Whose the goofball running the company to the ground?